The EU Health Technology Assessment Regulations: Pricing & Reimbursement Opportunities of Novel Therapeutics in Europe
06 Sep 2023
16:45
Stream 2
16:45pm Chair Introduction
Chairperson: Oresta Piniazhko, Director, HTA Department, State Expert Center, MOH of Ukraine
Panel Participants
- Paolo Morgese, Head of Public Affairs, Europe, Alliance for Regenerative Medicine
- Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics
- Lydia Frick, Manager Market Access, SKC Beratungsgesellchaft
- Åse Rosenqvist, Nordic Business Unit Lead Cell Therapy, Janssen
- Miguel Forte, Chief Executive Officer, Kiji Therapeutics, President-Elect, ISCT